SIRT1 inhibition during the hypoinflammatory phenotype of sepsis enhances immunity and improves outcome.

Abstract excerpt

Mechanism-based sepsis treatments are unavailable, and their incidence is rising worldwide. Deaths occur during the early acute phase of hyperinflammation or subsequent postacute hypoinflammatory phase with sustained organ failure. The acute sepsis phase shifts rapidly, and multiple attempts to treat early excessive inflammation have uniformly failed. We reported in a sepsis cell model and human sepsis blood...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carbazoles
• Share to Endotoxins